[go: up one dir, main page]

FR2509175B1 - THERAPEUTIC PREPARATION HAVING EXCELLENT ABSORPTION PROPERTIES - Google Patents

THERAPEUTIC PREPARATION HAVING EXCELLENT ABSORPTION PROPERTIES

Info

Publication number
FR2509175B1
FR2509175B1 FR8203123A FR8203123A FR2509175B1 FR 2509175 B1 FR2509175 B1 FR 2509175B1 FR 8203123 A FR8203123 A FR 8203123A FR 8203123 A FR8203123 A FR 8203123A FR 2509175 B1 FR2509175 B1 FR 2509175B1
Authority
FR
France
Prior art keywords
absorption properties
excellent absorption
therapeutic preparation
therapeutic
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8203123A
Other languages
French (fr)
Other versions
FR2509175A1 (en
Inventor
Masataka Morishita
Renji Aikawa
Shigeo Katsuragi
Yoshiaki Yamamoto
Kenichi Sugimoto
Kazuyoshi Nishiie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyo Jozo KK
Original Assignee
Toyo Jozo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3270581A external-priority patent/JPS57146721A/en
Priority claimed from JP57004222A external-priority patent/JPS58140026A/en
Application filed by Toyo Jozo KK filed Critical Toyo Jozo KK
Publication of FR2509175A1 publication Critical patent/FR2509175A1/en
Application granted granted Critical
Publication of FR2509175B1 publication Critical patent/FR2509175B1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
FR8203123A 1981-03-06 1982-02-25 THERAPEUTIC PREPARATION HAVING EXCELLENT ABSORPTION PROPERTIES Expired FR2509175B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3270581A JPS57146721A (en) 1981-03-06 1981-03-06 Improver for absorption
JP57004222A JPS58140026A (en) 1982-01-14 1982-01-14 Pharmaceutical having improved absorbability

Publications (2)

Publication Number Publication Date
FR2509175A1 FR2509175A1 (en) 1983-01-14
FR2509175B1 true FR2509175B1 (en) 1987-01-16

Family

ID=26337952

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8203123A Expired FR2509175B1 (en) 1981-03-06 1982-02-25 THERAPEUTIC PREPARATION HAVING EXCELLENT ABSORPTION PROPERTIES

Country Status (4)

Country Link
CA (1) CA1188987A (en)
DE (1) DE3207480A1 (en)
FR (1) FR2509175B1 (en)
GB (1) GB2095994B (en)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0093551B1 (en) * 1982-04-30 1991-01-16 Ajinomoto Co., Inc. Pharmaceutical composition
US4692441A (en) * 1985-08-16 1987-09-08 Merck & Co., Inc. Chorine esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities
US4731360A (en) * 1985-08-16 1988-03-15 Merck & Co., Inc. Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal compartments
DE3726324A1 (en) * 1987-08-07 1989-02-16 Hoechst Ag CYCLOPEPTIDE AS RESORPTION FOLDER IN APPLICATION TO THE MEAT
SE463851B (en) * 1988-09-02 1991-02-04 Amsu Ltd COMPOSITION FOR TREATMENT OF ERECT DYSFUNCTION THROUGH URETRA
DD293488A5 (en) * 1989-02-22 1991-09-05 Berlin-Chemie Ag, PROCESS FOR PREPARING MEDICAMENT FOR RECTAL APPLICATION
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
US6221367B1 (en) 1992-06-15 2001-04-24 Emisphere Technologies, Inc. Active agent transport systems
US5693338A (en) 1994-09-29 1997-12-02 Emisphere Technologies, Inc. Diketopiperazine-based delivery systems
US6331318B1 (en) 1994-09-30 2001-12-18 Emisphere Technologies Inc. Carbon-substituted diketopiperazine delivery systems
US5578323A (en) 1992-06-15 1996-11-26 Emisphere Technologies, Inc. Proteinoid carriers and methods for preparation and use thereof
US6099856A (en) 1992-06-15 2000-08-08 Emisphere Technologies, Inc. Active agent transport systems
US5629020A (en) 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US5447728A (en) * 1992-06-15 1995-09-05 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
FR2676922B1 (en) * 1991-06-03 1995-01-20 Givaudan Lavirotte COSMETIC APPLICATIONS OF N-ACYL DERIVATIVES OF MIXTURES OF AMINO ACIDS DERIVED FROM VEGETABLE PROTEIN HYDROLYSATES.
US5792451A (en) 1994-03-02 1998-08-11 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
US5811127A (en) 1992-06-15 1998-09-22 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US5401516A (en) 1992-12-21 1995-03-28 Emisphere Technologies, Inc. Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
US5709861A (en) 1993-04-22 1998-01-20 Emisphere Technologies, Inc. Compositions for the delivery of antigens
ATE298561T1 (en) 1993-04-22 2005-07-15 Emisphere Tech Inc ORAL DOSAGE FORM
US6610329B2 (en) 1993-04-22 2003-08-26 Emisphere Technologies Inc. Compositions for the delivery of antigens
US5958457A (en) 1993-04-22 1999-09-28 Emisphere Technologies, Inc. Compositions for the delivery of antigens
US5643957A (en) 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US20010003001A1 (en) 1993-04-22 2001-06-07 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
EP0706375A4 (en) * 1993-06-14 1996-11-06 Emisphere Tech Inc Proteinoid carriers
CN1151836C (en) 1995-03-31 2004-06-02 艾米斯菲尔技术有限公司 Compound and compositions for delivering active agents
US5965121A (en) 1995-03-31 1999-10-12 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6090958A (en) 1995-03-31 2000-07-18 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6001347A (en) 1995-03-31 1999-12-14 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5866536A (en) 1995-03-31 1999-02-02 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5989539A (en) 1995-03-31 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5650386A (en) 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
US5820881A (en) 1995-04-28 1998-10-13 Emisphere Technologies, Inc. Microspheres of diamide-dicarboxylic acids
US5667806A (en) 1995-06-07 1997-09-16 Emisphere Technologies, Inc. Spray drying method and apparatus
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
US5824345A (en) 1995-06-07 1998-10-20 Emisphere Technologies, Inc. Fragrances and flavorants
US6051258A (en) 1995-06-07 2000-04-18 Emisphere Technologies, Inc. Proteinoid emulsions and methods for preparation and use thereof
GB2320248B (en) 1995-09-11 1999-04-14 Emisphere Tech Inc Method for preparing omega-aminoalkanoic acid derivatives from cycloalkanones
IL126318A (en) 1996-03-29 2004-09-27 Emisphere Tech Inc Compounds and compositions for delivering active agents and some novel carrier compounds
WO1997047288A1 (en) 1996-06-14 1997-12-18 Emisphere Technologies, Inc. Microencapsulated fragrances and method for preparation
WO1998021951A1 (en) 1996-11-18 1998-05-28 Emisphere Technologies, Inc. Methods and compositions for inducing oral tolerance in mammals
US6060513A (en) 1997-02-07 2000-05-09 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5879681A (en) 1997-02-07 1999-03-09 Emisphere Technolgies Inc. Compounds and compositions for delivering active agents
US5939381A (en) 1997-02-07 1999-08-17 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5990166A (en) 1997-02-07 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5804688A (en) 1997-02-07 1998-09-08 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5876710A (en) 1997-02-07 1999-03-02 Emisphere Technologies Inc. Compounds and compositions for delivering active agents
US6313088B1 (en) 1997-02-07 2001-11-06 Emisphere Technologies, Inc. 8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
US5863944A (en) 1997-04-30 1999-01-26 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5962710A (en) 1997-05-09 1999-10-05 Emisphere Technologies, Inc. Method of preparing salicyloylamino acids
US6440929B1 (en) 1998-07-27 2002-08-27 Emisphere Technologies, Inc. Pulmonary delivery of active agents
DE69925276T2 (en) 1998-07-27 2005-10-06 Emisphere Technologies, Inc. SUBSTANCES AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
PL212652B1 (en) 1998-08-07 2012-11-30 Emisphere Tech Inc Compounds and compositions for delivering active agents
BR0008590A (en) 1999-01-08 2001-10-30 Emisphere Tech Inc Polymeric delivery agent, composition, unit dosage form, method for administering a biologically active agent to an animal requiring the agent, method for preparing a composition; it's composed
US7084279B1 (en) 1999-02-11 2006-08-01 Emisphere Technologies Inc. Oxadiazole compounds and compositions for delivering active agents
WO2000059863A1 (en) 1999-04-05 2000-10-12 Emisphere Technologies, Inc. Disodium salts, monohydrates, and ethanol solvates
US7129274B1 (en) 1999-11-05 2006-10-31 Emisphere Technologies Inc. Phenoxy carboxylic acid compounds and compositions for delivering active agents
US7279597B1 (en) 1999-11-05 2007-10-09 Emisphere Technologies, Inc. Phenyl amine carboxylic acid compounds and compositions for delivering active agents
DE60038183T2 (en) 1999-12-16 2009-02-19 Emisphere Technologies, Inc. COMPOUNDS AND COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS
WO2001051454A1 (en) 2000-01-13 2001-07-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
EP1299348B1 (en) 2000-06-29 2008-04-09 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
KR101196176B1 (en) 2006-09-27 2012-11-01 아사히 가세이 파마 가부시키가이샤 Agent for preventing development of reflex sympathetic dystrophy after stroke
KR101686271B1 (en) 2009-11-18 2016-12-13 아사히 가세이 파마 가부시키가이샤 Preventive and/or therapeutic and/or aggravation suppressing agent for human arthritis deformans
IL238101A (en) * 2015-04-01 2017-01-31 Neodel Tec Ltd Method for preparation of n-acyl peptides, polypeptides and proteins
BR112020006690A2 (en) * 2017-10-05 2020-10-06 Receptor Holdings, Inc. plant-based compositions with enhanced bioavailability

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470M (en) * 1962-03-13 1964-04-20 Mead Johnson & Co Therapeutic composition.
GB1294664A (en) * 1968-12-31 1972-11-01 Unilever Ltd Modified proteins
FR2074632B1 (en) * 1970-01-13 1973-01-12 Roussel Uclaf
GB1485694A (en) * 1975-01-22 1977-09-14 Ajinomoto Kk Gelling agents
GB2051574B (en) * 1979-05-10 1984-01-18 Kyoto Pharma Ind Adjuvant for promoting absorption of pharmacologically active substances through the rectum
US4436726A (en) * 1980-12-15 1984-03-13 Fujisawa Pharmaceutical Co., Ltd. N-Acylpeptide compound, processes for the preparation thereof and the pharmaceutical compositions

Also Published As

Publication number Publication date
CA1188987A (en) 1985-06-18
DE3207480C2 (en) 1991-06-06
DE3207480A1 (en) 1982-10-07
FR2509175A1 (en) 1983-01-14
GB2095994A (en) 1982-10-13
GB2095994B (en) 1985-10-02

Similar Documents

Publication Publication Date Title
FR2509175B1 (en) THERAPEUTIC PREPARATION HAVING EXCELLENT ABSORPTION PROPERTIES
FR2487349B1 (en) HYDRONAPHTHALENE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
BE891917A (en) HEMODIALYSIS STIMULATOR
FR2543550B1 (en) NOVEL TETRAHYDROXY-3 ', 4', 5.7 FLAVONE DERIVATIVES, THEIR PREPARATION METHOD AND THEIR THERAPEUTIC USE
IT1148006B (en) STARCHES EQUIPPED WITH PHARMACEUTICAL PROPERTIES AND THEIR PREPARATION
IT1150622B (en) POLYSACCHARIDES EQUIPPED WITH ANTI-CARCINOGENE ACTIVITY AND PROCEDURE FOR THEIR PREPARATION
FR2497669B1 (en) PHARMACEUTICAL PREPARATION HAVING EXCELLENT ABSORPTION PROPERTIES
KR900007411A (en) NB-818's easy absorbent agent
IT1157217B (en) BLOOD OXYGENATION PROCEDURE AND DEVICE
KR890701004A (en) Preparation of plant with improved physiological effect and use of the plant
IT1223529B (en) IMMUNODOMINATING PROTECTIVE EPITOPE CONTAINED IN THE SUBUNITY S1 OF PERTOSSE TOXIN
BE890376R (en) PREPARATION OF ACETALDEHYDE
MA19965A1 (en) 3 ', 5'-DIARABINOSIDES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2544309B1 (en) HYDROXYLATED DIPHENYLAZOMETHINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
ES516534A0 (en) "2-ISOPROPYLAMINE-PIRIMIDINE-N-OXIDE PREPARATION PROCEDURE".
ES511281A0 (en) "FUSAFUNGIN PREPARATION PROCEDURE".
ES263793Y (en) "THERAPEUTIC PILLOW".
IT8529517V0 (en) AUDIOPHONE GUIDE TO THE CITY
ES259928Y (en) CHILDREN'S AUDIOMETER
KR880001256U (en) Kita's sound
FI940103A (en) Preparation of 2 ', 3'-deoxy-2', 3'-didehydronucleosides
SE8404465D0 (en) MEDICAL PREPARATION
IT1178208B (en) DISPOSABLE DIAPERS WITH IMPROVED ABSORPTION PROPERTIES
FR2612241B1 (en) APARTMENT SAFE
CA44202S (en) Invalid's chair

Legal Events

Date Code Title Description
ST Notification of lapse